| Washington
Days 2004
NHF's
Annual Legislative Advocacy Conference
March 10 to 12, 2004
Over 150 members of the bleeding disorders community met March 10-12,
2004 for this year’s NHF Annual Legislative Advocacy Conference
in Washington DC. 126 Congressional office visits were scheduled and
37 Congressional Members met with members of the community themselves.
This year’s program included many successful components including:
Wednesday, March 10:
Evening Reception and Issue Briefing
Position Papers
Thursday, March 11:
Breakfast and Briefing on Capitol Hill followed by Congressional Visits
Friday, March 12:
State Advocacy Workshop Only
Presentations
- The Role of Medicaid
Joan Alker
Georgetown Health Policy Institute
- Health Insurance Reform and Access
Karen Pollitz
Georgetown Health Policy Institute
- Individual insurance
market trends
- High Risk Pools
Beneficiary Cost Burden
- High Risk Pools Benefit
Maximums
- Kaiser Family Foundation
- Commonwealth Foundation
- Stateside Associates, Inc
Fundamentals of Advocacy
Michael Behm and Sam Witt
Stateside Associates
Medicaid and the States
Kate Paleczny
Stateside Associates
-
Breakout Points
ACCESS TO HTCS
Participants: Linda Belling, Gareth Griffiths, Shaun Shokrollahi, Claudia
Smith, Roberta Smith, Scott Sorenson
Discussion Points:
•
Work with Insurer to gain access to HTC
•
Work with Insurer to get cost per unit and shop around Homecare
•
Work with Chapter to offset annual visits
•
Access NHF for information on:
o Recombinant care
o CDC statistics on HTC care to add to
information packet
•
While visiting legislators/lawmakers – leave material and leave
a keep sake to remember your issue. Have the kids make your keepsake.
PRIOR AUTHORIZATION/PREFERRED DRUG LISTS
Participants: Jeff Cornett, Barbara Gordon, Louise Hardaway, Bobbie Kincaid,
Tony Maynard, Catherine Wilson, Colleen Wilson, Amanda Tuberdyck
Discussion Points:
•
Prior authorization is a restriction on access to factor – without
access patients have to go to the emergency room for therapy.
•
Need to:
o Implement legislation to exempt factor from prior authorization. Cite
the uniqueness of products – they are not simply drugs
o Include all products on preferred drug lists by brand name
- South Carolina
Medicaid only includes one plasma-derived product and one recombinant
product
COVERAGE FOR CLOTTING FACTOR
Participants: Warren Cranford , Kevin O’Connor, Diana Smith
Discussion Points:
•
Must recognize that concern for coverage of factor cannot be separated
from concern over cost of factor
•
Constant worry about reaching maximum lifetime caps
•
There is often a need to change jobs for health coverage security – adequate
clotting factor coverage is a factor when looking/choosing employment
•
Always looking over your sholder – don’t want to “rock
the boat” and draw attention to amount of health insurance you
use
MEDICAID ACCESSIBILITY
Participants: Patrick Collins, Pam Doell, Elizabeth Fung, Jim Knappe-Langworthy,
Kathleen Montgomery, Teresa Ramirez, Michelle Rice, Bobbi Walker, Carl
Weixler, Edwin Wilson
Discussion Points:
•
Chapters have a need for:
o Access to each other – share stories and information within different
states
o Chapter resources should be shared among chapters and made available
o Chat room/forum to discuss general goals and specific plans
o Menu of possible solutions/options
PRODUCT CHOICE/PROVIDER CHOICE
Participants: Debby O’Connor, Dorothy O’Connor, Brandy Stewart,
Shirley Wilson-Oslund
Discussion Points:
•
It is necessary to emphasize the need to have access to all products – cannot
mirror South Carolina one recombinant and one monoclonal product for
Medicaid
•
Emphasize that all brands are not the same, they are not interchangeable
•
Emphasize the patient/physician relationship. It is up to the physician
to decide the best course of treatment/products for the patient - this
relationship must be respected.
HIGH RISK POOLS
Participants: Dianna Smith, Ray Stanhope, Doug Thompson, Meredith Zerbe
Discussion Points:
•
Educate yourself about high risk pools:
o Go to meetings, get community members
on the board
o Get to know state high risk pool benefits
– lifetime max?
single product restriction?
o Find out if a third party payor is permitted to
pay for premiums
•
Educate others – let them know $1 million cap is
not enough
o Connection with high risk pools can help
make a case with private insurers
View the event schedule >>
Contact Yalda Kasaean at (800) 424-2634, ext. 3742 or e-mail ykasaean@hemophilia.org if
you have any questions about registration or the Washington Days
program.
|
 |
Click
here to read NHF's Privacy Policy
Disclaimer
The information contained on the NHF web site is provided for your general information
only. NHF does not give medical advice or engage in the practice of medicine.
NHF under no circumstances recommends particular treatment for specific individuals
and in all cases recommends that you consult your physician or local treatment
center before pursuing any course of treatment.
All information and content on this web site are
protected by copyright. All rights are reserved. Users are prohibited from modifying,
copying, distributing, transmitting, displaying, publishing, selling, licensing,
creating derivative works, or using any information available on or through the
site for commercial or public purposes. |